The fund manager knew there was going to be trouble after he read a Wall Street Journal story that accused the startup of overbilling drug companies and misleading them about the effectiveness of their advertising.
The fund manager knew there would be trouble after he read a Wall Street Journal story that accused the startup of overbilling and misleading drug companies.